Joint Research with View to Developing Regenerative Medicine Product for Type 1 Diabetes by Producing Pancreatic Beta Cells Through Direct Reprogramming of Bone Marrow-Derived Mesenchymal Stem Cells

External Document
AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!